We're desperate for a coronavirus cure, but at what cost to the human guinea pigs? | Kenan Malik
by Kenan Malik from Science | The Guardian on (#52P2F)
Big drugs companies have long favoured outsourcing clinical trials to poor countries with lax regulations to cut costs and maximise profit
" See all our coronavirus coverage
Last week, in Oxford, the first volunteers in the first European human trial were injected with a potential coronavirus vaccine. At the same time, Pakistan's National Institute of Health received an offer from the Chinese pharmaceutical firm Sinopharm International Corp to take part in a trial of another potential coronavirus vaccine.
Continue reading...